Authors

• Zhenling Li (ORCID: https://orcid.org/0000-0002-6623-1683)
• Jiangtao Li (ORCID: https://orcid.org/0000-0003-1406-5545)
• Yazi Yang (ORCID: https://orcid.org/0009-0005-9144-4292)
• Feng Shi (ORCID: https://orcid.org/0000-0003-1337-5293)
• Ru Feng (ORCID: https://orcid.org/0000-0003-4585-554X)
• Hui Liu (ORCID: https://orcid.org/0000-0002-8166-0216)
• Fei Wu (ORCID: https://orcid.org/0000-0001-6689-6135)
• Jian Li (ORCID: https://orcid.org/0000-0002-4549-0694)
• Ting Wang (ORCID: https://orcid.org/0000-0001-5073-2224)
• Ting He (ORCID: https://orcid.org/0000-0002-2870-8874)
• Chunli Zhang (ORCID: https://orcid.org/0000-0003-2431-607X)
• Guanghua Liu (ORCID: https://orcid.org/0000-0002-6701-1885)
• Xin‐an Lu (ORCID: https://orcid.org/0000-0003-4721-1684)
• Jiefei Bai
• Lie Ma (ORCID: https://orcid.org/0009-0006-4964-4909)
• Yanping Ding

Institutions

• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• China-Japan Friendship Hospital (CN)
• Peking Union Medical College Hospital (CN)
• Chinese PLA General Hospital (CN)
• China National Pharmaceutical Group Corporation (China) (CN)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2024-09-01

DOI

https://doi.org/10.1136/jitc-2024-009476

Citations

7

Primary Topic

CAR-T cell therapy research

Type

article

Field-Weighted Citation Impact

1.98